Argonne National Laboratory Demonstration of SHINE Process Produces Commercial-Grade Medical Isotopes
Argonne National Laboratory (Argonne) and SHINE Medical Technologies, Inc. announced today that Argonne successfully demonstrated the production, separation and purification of molybdenum-99 (Mo-99) from SHINE’s innovative liquid target.
The resulting Mo-99 product purity was equivalent to the Mo-99 used in the supply chain today. The demonstration—known as Mini-SHINE—uses the same process flows that will be used in the SHINE manufacturing facility and further validates SHINE’s technical approach.
See also: Argonne – Mo-99 Press Release FINAL
SHINE Medical Technologies, a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that the Company’s primary regulator, the Nuclear Regulatory Commission (NRC), has released for public review and comment the draft Environmental Impact Statement (EIS) for the SHINE medical isotope production facility in Janesville, WI. The draft EIS provides an analysis of the environmental, social, and economic impacts of the proposed facility.
The NRC staff’s preliminary recommendation is that SHINE be issued a permit to construct its facility, pending satisfactory completion of the NRC’s safety review. The new manufacturing plant…read more +
SHINE Medical Technologies and Phoenix Nuclear Labs (PNL) announced today that they have entered into an exclusive, long-term development and supply agreement. This agreement builds on an existing partnership and lays the foundation for a commercial relationship going forward.
“I’m extremely proud that SHINE has selected PNL to provide the accelerator hardware needed to operate their facility,” said Ross Radel, President of PNL. “Their medical isotope production facility will have a major impact on millions of patients every year. Everyone at PNL is thrilled to be a part of this project and is committed to supporting SHINE by delivering the…read more +
Phoenix Nuclear Labs (PNL) announced today that it closed a $2M equity fundraising round to support several key hires and to continue the scale up of its manufacturing infrastructure, as it transitions from R&D into commercialization of its platform neutron generator technology.
The financing round was led by Venture Management LLC, a Madison-based investment firm. Other participants in the round included Wisconsin Investment Partners, New Capital Fund, Knox LLC, the Chippewa Valley Angel Investment Network, DJW Advisors, and Mendota Venture Capital.
MONONA, Wis. – SHINE Medical Technologies, Inc. (SHINE) announced today that it executed a term sheet providing for up to $125 million of debt and equity financing with Deerfield Management Company, L.P. (Deerfield), a New York headquartered healthcare investment firm. SHINE plans to build a new manufacturing plant in Wisconsin to produce more than a quarter of world supply of the most commonly-used isotope in nuclear medicine, molybdenum-99 (moly-99).
Under the terms of the financing, Deerfield would provide SHINE the debt financing in milestone-driven phases. In addition, a portion of Deerfield’s commitment would include participation in the concurrent…read more +
Monona, Wis. – Phoenix Nuclear Labs (PNL) announced today that it has been awarded a one-year, $3 million contract by the U.S. Army to build an advanced neutron radiography unit.
The neutron imaging system will be used for the nondestructive inspection of munitions, pyrotechnics and other critical defense components. The company will deliver an upgraded, second-generation version of a similar system that it delivered to Picatinny Arsenal in 2013. The new system is expected to generate 10 times the amount of neutrons, enabling faster performance, and will be capable of producing digital images that will improve the system’s ability to…read more +
FOR IMMEDIATE RELEASE
Monona, Wis. –Phoenix Nuclear Labs (PNL) announced today that retired Army Lt. Gen. William Phillips has joined its seven-member board of directors.
Phillips recently retired after nearly 38 years of service and currently resides in Alexandria, Va. Over the course of his career, Phillips served as an aviator, an acquisition commander in Iraq and Afghanistan, and as the highest-ranking military acquisition officer in the Army.
“I’m excited and inspired to join the team at Phoenix Nuclear Labs,” said Phillips. “The company’s impressive technologies have the potential to make a major positive impact on the military, particularly in…read more +
MONONA, Wis. – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it closed a $2.4 million financing. The financing will be used to cover operating costs as the Company progresses toward obtaining a construction permit from the Nuclear Regulatory Commission, which is necessary to commence construction on SHINE’s planned full-scale manufacturing facility to be built in Janesville, Wisconsin.
MONONA, Wis. – SHINE Medical Technologies and Phoenix Nuclear Labs (PNL) announced today that they successfully operated their second-generation neutron driver prototype for 24 consecutive hours with 99% uptime. Completion of this milestone is an important demonstration of the reliability and robustness of the PNL neutron driver, which is a key enabling technology for SHINE’s isotope production facility.
Phoenix Nuclear Labs (PNL) announced today that it has successfully completed preliminary testing of an explosives detection system funded by the US Army. PNL’s neutron-based interrogation system is capable of detecting so-called “undetectable explosives” because it detects the explosive material itself rather than specific chemical signatures or other associated components such as metallic casing or triggering mechanisms.